Insulin Degludec
6 NDCs across 1 manufacturer|3 Generic,3 Brand
Insulin Degludec is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $1.9 billion on Insulin Degludec across 2.3 million claims for 622,000 beneficiaries.
Insulin Degludec is available as 6 NDCs from 1 manufacturer (3 generic, 3 brand), with NADAC prices from $9.02 to $22.74 per ML — the most expensive product costs about 2.5× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
3G / 3B
Manufacturers
1
competing in market
Price Spread
$9.02 – $22.74
per ML
7d Activity
avg +0.0% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Novo Nordisk manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Insulin Analog class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing INSULIN DEGLUDEC
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
INSULIN DEGLUDEC FLEXTOUCH 200 UNIT/ML PEN | $22.7408 per ML | — |
TRESIBA FLEXTOUCH 200 UNIT/ML | $18.0703 per ML | -0.01% |
INSULIN DEGLUDEC FLEXTOUCH 100 UNIT/ML PEN | $11.3904 per ML | — |
INSULIN DEGLUDEC 100 UNIT/ML VIAL | $11.3401 per ML | — |
TRESIBA FLEXTOUCH 100 UNIT/ML | $9.0358 per ML | -0.01% |
TRESIBA 100 UNIT/ML VIAL | $9.0243 per ML | +0.04% |
Frequently Asked Questions
What is Insulin Degludec used to treat?
Insulin Degludec is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Insulin Degludec?
In 2024, Medicare Part D spent $1.9 billion on Insulin Degludec across 2.3 million claims for 622,000 beneficiaries.
How many Insulin Degludec products are on the market?
The Insulin Degludec drug market contains 6 NDCs from 1 manufacturer — 3 generic and 3 brand products.
What is the price range for Insulin Degludec?
NADAC reference prices for Insulin Degludec range from $9.0243 to $22.7408 per ML — the most expensive product costs about 2.5× the cheapest.
Is generic Insulin Degludec cheaper than brand?
The average generic NADAC for Insulin Degludec is $15.1571 per ML, versus $12.0435 for brand-labeled products — brand is currently about 21% cheaper on average.
Which manufacturers make Insulin Degludec?
1 manufacturer lists Insulin Degludec in NADAC. Ranked by number of NDCs, the largest are Novo Nordisk (6).
How has the price of Insulin Degludec changed recently?
Over the past 7 days, 1 Insulin Degludec NDC rose and 2 fell, with a market-wide average change of +0.0%.